Drug-mediated changes of tumour cell immunogenicity and antigenicity.
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D002460:Cell Line; D003606:Dacarbazine / Q000494:pharmacology*; D000939:Epitopes / Q000276:immunology; D005260:Female; D006649:Histocompatibility Antigens / Q000276:immunology; D007167:Immunotherapy; D007942:Leukemia, Experimental / Q000276:immunology; D008223:Lymphoma / Q000276:immunology / Q000628:therapy; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology*
D000951:Antigens, Neoplasm; D000939:Epitopes; D006649:Histocompatibility Antigens; D003606:Dacarbazine